Showing results (31-40 of 118) with videos related to

Sort By:
Pageof 12
Frontiers in Oncology|August 12, 2024
Dexamethasone-sparing strategies in anthracycline and cyclophosphamide-based chemotherapy with a focus on 5-HT3 receptor antagonists: a network meta-analysisDaichi Watanabe, Hirotoshi Iihara, Ryo Kobayashi, et al.
International Journal of Clinical Oncology|October 18, 2015
Control of chemotherapy-induced nausea in patients receiving outpatient cancer chemotherapyHirotoshi Iihara, Hironori Fujii, Chiaki Yoshimi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 22, 2008
[A retrospective analysis of adverse events based on a dose and a schedule in patients who underwent paclitaxel- containing chemotherapy]Tomoaki Yoshimura, Kouseki Hirade, Hirotoshi Iihara, et al.
Molecular and Clinical Oncology|April 27, 2021
Evaluation of clinical pharmacist interventions for adverse events in hospitalized patients with thoracic cancer receiving cancer chemotherapyHirotoshi Iihara, Chiemi Hirose, Norihiko Funaguchi, et al.
International Journal of Systematic and Evolutionary Microbiology|January 16, 2007
dnaJ gene sequence-based assay for species identification and phylogenetic grouping in the genus StaphylococcusMohammad Monir Shah, Hirotoshi Iihara, Makiko Noda, et al.
Anticancer Research|February 27, 2026
Effectiveness of a Physician-Pharmacist Collaborative Protocol for Universal Hepatitis B Virus Screening Prior to Chemotherapy in Cancer PatientsHiroko Kato-Hayashi, Kenji Imai, Masayuki Ishida, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 20, 2023
2023 updated MASCC/ESMO Consensus recommendations: Prevention of nausea and vomiting following moderately emetic risk antineoplastic agentsFlorian Scotté, Lee Schwartzberg, Hirotoshi Iihara, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 26, 2023
Efficacy and safety of 5HT3RA, DEX, and NK1RA for the prevention of FOLFIRINOX-induced nausea and vomiting in patients with pancreatic cancer: a retrospective cohort studyShiori Hishida-Sadaka, Hirotoshi Iihara, Koichi Ohata, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 13, 2025
Efficacy of triplet antiemetic prophylaxis against chemotherapy-induced nausea and vomiting in patients with soft tissue sarcomas receiving consecutive-day doxorubicin and ifosfamide therapyYunami Yamada, Hirotoshi Iihara, Akihito Nagano, et al.
Journal of Cancer|April 8, 2016
Comparison of the Control of Nausea and Vomiting among Several Moderately Emetic-Risk Chemotherapy RegimensHirotoshi Iihara, Masashi Ishihara, Hironori Fujii, et al.
Pageof 12